Khiron OTC Stock Financials

KHRNF -  USA Stock  

USD 0.23  0.01  4.55%

Understanding current and past Khiron Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Khiron Life's financial statements are interrelated, with each one affecting the others. For example, an increase in Khiron Life's assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Khiron Life's financials over time to get the whole picture.
We recommend to make use of Khiron Life Sciences fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking you can employ it to find out if Khiron Life Sciences is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate twenty-seven available fundamentals for Khiron Life, which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Khiron Life Sciences financials, including its price to book, total debt, market capitalization, as well as the relationship between the ebitda and cash flow from operations . As Khiron Life Sciences appears to be a penny stock we also strongly suggest to check its shares owned by insiders numbers. Use Khiron Life to enhance returns of your portfolios. The stock experiences a very speculative upward sentiment. The trend is possibly hyped up. Check odds of Khiron Life to be traded at $0.2875 in 90 days.

Search Fundamentals 

 
Refresh
With this module, you can analyze Khiron financials for your investing period. You should be able to track the changes in Khiron Life individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  Chance Of Financial Distress
Less than 28
Khiron Life Sciences has less than 28 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Khiron Life otc stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Khiron Life's official financial statements usually reflect Khiron Life's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Khiron Life Sciences. For example, before you start analyzing numbers published by Khiron accountants, it's critical to develop an understanding of what Khiron Life's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Khiron Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Khiron Life's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Khiron Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Khiron Life Sciences. Please utilize our Beneish M Score to check the likelihood of Khiron Life's management to manipulate its earnings.

Khiron Life Company Summary

Khiron Life competes with Catalent, and Dr Reddys. Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America, North America, and Europe. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands develops CBD-based cosmeceutical products under the Kuida brand name and operates Zerenia clinic in Medellin and Peru. Khiron Life is traded on OTC Exchange in the United States.
InstrumentUSA OTC Stock View All
ExchangeOTC Exchange
Business Address2300-550 Burrard Street
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic
BenchmarkDOW
Websitewww.khiron.ca
Phone705 527 3564
CurrencyUSD - US Dollar

Khiron Life Key Financial Ratios

Generally speaking, Khiron Life's financial ratios allow both analysts and investors to convert raw data from Khiron Life's financial statements into concise, actionable information that can be used to evaluate the performance of Khiron Life over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Khiron Life Sciences reports annually and quarterly.

Khiron Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Khiron Life competition to find correlations between indicators driving Khiron Life's intrinsic value. More Info.
Khiron Life Sciences is rated third overall in ebitda category among related companies. It is currently regarded as number one stock in shares owned by insiders category among related companies .

Khiron Life Sciences Systematic Risk

Khiron Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Khiron Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Khiron Life Sciences correlated with the market. If Beta is less than 0 Khiron Life generally moves in the opposite direction as compared to the market. If Khiron Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Khiron Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Khiron Life is generally in the same direction as the market. If Beta > 1 Khiron Life moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

About Khiron Life Financials

What exactly are Khiron Life Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Khiron Life's income statement, its balance sheet, and the statement of cash flows. Potential Khiron Life investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Khiron Life investors may use each financial statement separately, they are all related. The changes in Khiron Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Khiron Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Khiron Life September 20, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Khiron Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Khiron Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Khiron Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Khiron OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Khiron Life's daily price indicators and compare them against related drivers.
Information Ratio(0.13)
Maximum Drawdown24.61
Value At Risk(8.00)
Potential Upside5.56
Please see Stocks Correlation. Note that the Khiron Life Sciences information on this page should be used as a complementary analysis to other Khiron Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Khiron OTC Stock analysis

When running Khiron Life Sciences price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
The market value of Khiron Life Sciences is measured differently than its book value, which is the value of Khiron that is recorded on the company's balance sheet. Investors also form their own opinion of Khiron Life's value that differs from its market value or its book value, called intrinsic value, which is Khiron Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Khiron Life's market value can be influenced by many factors that don't directly affect Khiron Life Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Khiron Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Khiron Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Khiron Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.